PHARMIGENE, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.5 TWD | -2.78% |
|
-5.41% | -15.46% |
| Apr. 30 | Pharmigene, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Pharmigene, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Quotes 5-day view
End-of-day quote Taipei Exchange| 2024-05-13 | 2024-05-14 | 2024-05-15 | 2024-05-16 | Today | 2024-05-16 | |
|---|---|---|---|---|---|---|
| Last | 18 NT$ | 18.1 NT$ | 18 NT$ | 18 NT$ | 17.5 NT$ | 17.5 NT$ |
| Volume | 30 200 | 21 717 | 19 200 | 200 | 22 200 | 22 200 |
| Change | -2.70% | +0.56% | -0.55% | 0.00% | -2.78% | -2.78% |
| Opening | 18.50 | 18.00 | 18.00 | 18.00 | 18.00 | 18 |
| High | 18.50 | 18.50 | 18.00 | 18.00 | 18.00 | 18 |
| Low | 18.00 | 17.90 | 18.00 | 18.00 | 17.40 | 17.4 |
Performance
| 1 day | -2.78% | ||
| 1 week | -5.41% | ||
| Current month | -9.79% | ||
| 1 month | -10.71% | ||
| 3 months | -10.49% | ||
| 6 months | -23.91% | ||
| Current year | -15.46% | ||
| 1 year | -24.24% | ||
| 3 years | -28.57% |
Volumes
marketsDaily volume
22 200
Avg. Volume 20 sessions
21 588
Avg. Volume 20 sessions TWD
377 790.00
Avg. Volume 20 sessions USD
11 738.31
Record volume 1
4 122 707
Record volume 2
3 695 338
Record volume 3
3 570 000
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (TWD)
909 057 835
Capitalization (USD)
28 245 336
Net sales (TWD)
132 707 000
Net sales (USD)
4 123 339
Free-Float
49.29 %
Free-Float capitalization (TWD)
448 089 405
Free-Float capitalization (USD)
13 922 586
Average Daily Capital Traded
0.04%
Highs and lows
1 week
17.40
18.50
1 month
17.4019.90
Current year
17.4021.10
1 year
17.4025.70
3 years
13.4026.70
5 years
13.4036.00
10 years
13.4036.00
Indicators
Moving average 5 days
17.92
Moving average 20 days
18.91
Moving average 50 days
19.43
Moving average 100 days
20.31
Price spread / (MMA5)
+2.40%
Price spread / (MMA20)
+8.06%
Price spread / (MMA50)
+11.03%
Price spread / (MMA100)
+16.06%
STIM
RSI 9 days
16.75
RSI 14 days
25.03
Sector Comparison - Bio Diagnostics & Testing
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -2.78% | -5.41% | -15.46% | -24.24% | 28.25M | ||
| -3.02% | -5.85% | -31.90% | -35.93% | 9.59B | ||
| -3.35% | +13.37% | -6.25% | -12.70% | 3.21B | ||
| -1.82% | -6.61% | +25.95% | +36.53% | 2.92B | ||
| +0.90% | -4.33% | -13.96% | -30.49% | 2.15B | ||
| -2.22% | +7.07% | -16.83% | -8.70% | 1.79B | ||
| +1.98% | +8.22% | +72.82% | -11.70% | 1.47B | ||
| +4.87% | +4.52% | +29.17% | +99.49% | 770M | ||
| +0.22% | +0.22% | -2.62% | -2.19% | 761M | ||
| -2.96% | +3.14% | -26.33% | -42.24% | 548M | ||
| -0.38% | -8.01% | +4.97% | - | 316M | ||
| -29.94% | -38.46% | -28.80% | -41.80% | 201M | ||
| -2.11% | +2.93% | -14.35% | -30.58% | 196M | ||
| -0.93% | +2.60% | +22.36% | +34.58% | 132M | ||
| -29.95% | -30.46% | -29.78% | -18.99% | 126M | ||
| -0.24% | -0.61% | -16.33% | -25.45% | 114M | ||
| Average | -4.47% | +0.47% | -2.96% | -7.63% | ||
| Weighted average by Cap. | -2.06% | +2.67% | -8.51% | -14.21% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -15.46% | ||
| 2023 | +4.28% | ||
| 2022 | -8.53% | ||
| 2021 | -13.20% | ||
| 2020 | +0.40% |
- Stock Market
- Equities
- 7595 Stock
- Quotes Pharmigene, Inc.
